Simple. There is still a low demand for our shares.
In Australia the market is very illiquid compared to the US. Probably, in the more efficient US we would be worth already a couple hundreds million as a Phase II company. But Australia is a peripheral market and we are seeing as such.
We will see if some interested parties are going soon to show up in the market (and not wIth pre built and pre signed low prIced cross trades), and a true demand and value wIll raIse.
We can just wait and wish the best for the incoming investors.
- Forums
- ASX - By Stock
- DLM
- Ann: CEO presentation to Broker Meets Biotech - Perth
Ann: CEO presentation to Broker Meets Biotech - Perth, page-55
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable